MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
Holding INKT?
Track your performance easily

MiNK Therapeutics (INKT) Financial Statements

115 Followers

MiNK Therapeutics Financial Overview

MiNK Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.489; its P/E ratio is -1.53; MiNK Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.74M$ -3.83M$ -5.50M$ -5.22M$ -6.34M
EBITDA$ -2.70M$ -3.78M$ -5.45M$ -5.17M$ -6.29M
Net Income Common Stockholders$ -2.70M$ -3.81M$ -5.46M$ -5.12M$ -6.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 9.30M$ 5.80M$ 3.40M$ 6.40M$ 10.60M
Total Assets$ 10.32M$ 6.89M$ 4.55M$ 7.46M$ 12.09M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -9.30M$ -5.80M$ -3.40M$ -6.40M$ -10.60M
Total Liabilities$ 26.90M$ 27.19M$ 22.61M$ 21.04M$ 21.61M
Stockholders Equity$ -16.58M$ -20.30M$ -18.06M$ -13.58M$ -9.47M
Cash Flow-
Free Cash Flow$ -2.29M$ -2.54M$ -3.04M$ -4.23M$ -4.19M
Operating Cash Flow$ -2.29M$ -2.54M$ -3.04M$ -4.21M$ -4.15M
Investing Cash Flow---$ -23.04K$ -37.02K
Financing Cash Flow$ 5.81M$ 5.01M$ -2.00$ 2.95K$ -75.70K
Currency in USD

MiNK Therapeutics Earnings and Revenue History

MiNK Therapeutics Debt to Assets

MiNK Therapeutics Cash Flow

MiNK Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis